Central serous chorioretinopathy associated with low dose systemic corticosteroid treatment of Behcet's disease
10.12701/yujm.2017.34.1.111
- Author:
Sungwook CHA
1
;
Kyung Jin KIM
;
Seongmin KWEON
;
Sinae LEE
;
Byungchul MIN
;
Eunsung KIM
;
Jungwook LEE
Author Information
1. Department of Internal Medicine, Busan St.Mary's Hospial, Busan, Korea. chafila@naver.com
- Publication Type:Case Report
- Keywords:
Steroid;
Behcet's syndrome;
Central serous chorioretinopathy
- MeSH:
Angiography;
Behcet Syndrome;
Capsule Opacification;
Central Serous Chorioretinopathy;
Glaucoma;
Humans;
Indocyanine Green;
Male;
Optic Neuritis;
Retinal Detachment;
Retinal Vasculitis;
Tomography, Optical Coherence;
Uveitis
- From:Yeungnam University Journal of Medicine
2017;34(1):111-114
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Central serous chorioretinopathy may induce poor eyesight and serous retinal detachment. However, its exact cause has not been well established thus far. It can be associated with systemic high-dose corticosteroid treatment mainly for young and middle-aged men and may spontaneously regress or recur after withdrawal from corticosteroid. After corticosteroid administration for Behcet's disease, it is necessary to identify any ocular symptoms. Behcet's disease can lead to the development of ocular complications, such as uveitis, hypopyon, retinal vasculitis, optic neuritis, angiogenesis, secondary cataract, and glaucoma. It is possible to diagnose any of these complications via optical coherence tomography and digital indocyanine green angiography. It is easy to neglect an ocular symptom that may appear after a low-dose corticosteroid treatment as an ocular complication in patients with Behcet's disease. Thus, we report on a case concerning high-dose corticosteroid treatment with a literature review.
